Hangzhou Zhongtai Cryogenic Technology Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Hangzhou Zhongtai Cryogenic Technology ha un patrimonio netto totale di CN¥3.3B e un debito totale di CN¥306.9M, che porta il suo rapporto debito/patrimonio netto a 9.3%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥4.8B e CN¥1.5B. L'EBIT di Hangzhou Zhongtai Cryogenic Technology è CN¥294.3M rendendo il suo rapporto di copertura degli interessi -12.3. Ha liquidità e investimenti a breve termine pari a CN¥1.1B.

Informazioni chiave

9.3%

Rapporto debito/patrimonio netto

CN¥306.88m

Debito

Indice di copertura degli interessi	-12.3x
Contanti	CN¥1.11b
Patrimonio netto	CN¥3.30b
Totale passività	CN¥1.48b
Totale attività	CN¥4.78b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Hangzhou Zhongtai Cryogenic Technology (SZSE:300435) Might Have The Makings Of A Multi-Bagger

Oct 18

Hangzhou Zhongtai Cryogenic Technology's (SZSE:300435) Upcoming Dividend Will Be Larger Than Last Year's

May 21

Solid Earnings May Not Tell The Whole Story For Hangzhou Zhongtai Cryogenic Technology (SZSE:300435)

May 01

Here's Why We Think Hangzhou Zhongtai Cryogenic Technology (SZSE:300435) Might Deserve Your Attention Today

Feb 29

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( CN¥2.5B ) di 300435 superano le sue passività a breve termine ( CN¥1.4B ).

Passività a lungo termine: Le attività a breve termine di 300435 ( CN¥2.5B ) superano le sue passività a lungo termine ( CN¥60.7M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 300435 ha più liquidità del suo debito totale.

Riduzione del debito: Il rapporto debito/patrimonio netto di 300435 si è ridotto da 24.7% a 9.3% negli ultimi 5 anni.

Copertura del debito: Il debito di 300435 è ben coperto dal flusso di cassa operativo ( 162.7% ).

Copertura degli interessi: 300435 matura più interessi di quanti ne paga, quindi la copertura dei pagamenti degli interessi non è un problema.

Hangzhou Zhongtai Cryogenic Technology Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.20 in 3Q 2023)

Hangzhou Zhongtai Cryogenic Technology (SZSE:300435) Might Have The Makings Of A Multi-Bagger

Investor sentiment deteriorates as stock falls 16%

Hangzhou Zhongtai Cryogenic Technology Corporation to Report Q3, 2024 Results on Oct 24, 2024

Investor sentiment improves as stock rises 25%

Second quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.30 in 2Q 2023)

Now 22% undervalued after recent price drop

Hangzhou Zhongtai Cryogenic Technology Corporation to Report First Half, 2024 Results on Aug 27, 2024

Now 20% undervalued after recent price drop

Hangzhou Zhongtai Cryogenic Technology's (SZSE:300435) Upcoming Dividend Will Be Larger Than Last Year's

Dividend increased to CN¥0.15

Solid Earnings May Not Tell The Whole Story For Hangzhou Zhongtai Cryogenic Technology (SZSE:300435)

Full year 2023 earnings released: EPS: CN¥0.92 (vs CN¥0.73 in FY 2022)

Hangzhou Zhongtai Cryogenic Technology Corporation, Annual General Meeting, May 08, 2024

Hangzhou Zhongtai Cryogenic Technology Corporation to Report Q1, 2024 Results on Apr 26, 2024

Hangzhou Zhongtai Cryogenic Technology Corporation (SZSE:300435) commences an Equity Buyback Plan for CNY 100 million worth of its shares, under the authorization approved on February 20, 2024.

Here's Why We Think Hangzhou Zhongtai Cryogenic Technology (SZSE:300435) Might Deserve Your Attention Today

Investor sentiment deteriorates as stock falls 15%

Hangzhou Zhongtai Cryogenic Technology Corporation to Report Fiscal Year 2023 Results on Apr 16, 2024

Third quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.20 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.21 in 2Q 2022)

High number of new and inexperienced directors

Hangzhou Zhongtai Cryogenic Technology Corporation Approves Board Elections

Hangzhou Zhongtai Cryogenic Technology Corporation to Report First Half, 2023 Results on Aug 25, 2023

Full year 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.16 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.18 in 2Q 2021)

Hangzhou Zhongtai Cryogenic Technology Declares Dividend for 2021, Payable on May 19, 2022

Hangzhou Zhongtai Cryogenic Technology Declares Dividend for 2021

Less than half of directors are independent

Hangzhou Zhongtai Cryogenic Technology Corporation Proposes Final Cash Dividend for the Year 2021

First quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.15 in 1Q 2021)

Now 21% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Now 20% undervalued after recent price drop

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.17 in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.12 in 2Q 2020)

Investor sentiment improved over the past week

Hangzhou Zhongtai Cryogenic Technology Corporation Announces Final Dividend for 2020

First quarter 2021 earnings released: EPS CN¥0.15 (vs CN¥0.09 in 1Q 2020)

Hangzhou Zhongtai Cryogenic Technology Corporation to Report Fiscal Year 2020 Results on Apr 22, 2021

New 90-day low: CN¥11.38

New 90-day low: CN¥12.25

New 90-day low: CN¥12.84

Third quarter earnings released

New 90-day high: CN¥17.78

Market bids up stock over the past week

New 90-day high - CN¥14.28

First half earnings released

Hangzhou Zhongtai Cryogenic Technology Corporation to Report First Half, 2020 Results on Aug 27, 2020

New 90-day high - CN¥12.07

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane